A novel pathway underlying the inhibitory effects of melatonin on isolated rat urinary bladder contraction

Korean Journal of Physiology and Pharmacology

Volumn 16, Issue 1, 2012, Pages 37-42

  Han, June Hyun ^a   Chang, In Ho ^b   Myung, Soon Chul ^b   Lee, Moo Yeol ^c   Kim, Won Yong ^c   Lee, Seo Yeon ^d   Lee, Shin Young ^e   Lee, Seung Wook ^f   Kim, Kyung Do ^b  

^a Korea Electric Power Research Institute (KEPRI)   (South Korea)

^b Chung Ang University College of Medicine   (South Korea)

^c Chung Ang University   (South Korea)

^d Catholic Kwandong University   (South Korea)

^e Seoul Medical Center   (South Korea)

^f Hanyang University Guri Hospital   (South Korea)

Author keywords

Melatonin; Nocturia; Overactive bladder; Smooth muscles; Urinary bladder

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; 4 AMINOPYRIDINE; ACETYLCHOLINE; BETHANECHOL; GLIBENCLAMIDE; MELATONIN; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; PHENYLEPHRINE; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHLORIDE; TETRYLAMMONIUM; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER CONTRACTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DETRUSOR MUSCLE; DRUG ACTIVITY; ELECTROSTIMULATION; NONHUMAN; SMOOTH MUSCLE;

EID: 84863379126     PISSN: 12264512     EISSN: None     Source Type: Journal    
DOI: 10.4196/kjpp.2012.16.1.37     Document Type: Article

References (22)

1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Van Kerrebroeck P, Victor A, Wein A. Standardisation Sub-Committee of the International Continence Society. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61:37-49. (Pubitemid 36151708)
2. Wein A, Lose GR, Fonda D. Nocturia in men, women and the elderly: a practical approach. BJU Int. 2002;90 Suppl 3:28-31. (Pubitemid 35422703)
3. Homma Y, Yamaguchi T, Kondo Y, Horie S, Takahashi S, Kitamura T. Significance of nocturia in the International Prostate Symptom Score for benign prostatic hyperplasia. J Urol. 2002;167:172-176. (Pubitemid 34024525)
4. Appell RA, Sand PK. Nocturia: etiology, diagnosis, and treatment. Neurourol Urodyn. 2008;27:34-39.
5. Garfinkel D, Laudon M, Nof D, Zisapel N. Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet. 1995;346:541-544.
6. Haimov I, Lavie P, Laudon M, Herer P, Vigder C, Zisapel N. Melatonin replacement therapy of elderly insomniacs. Sleep. 1995;18:598-603.
7. Drake MJ, Mills IW, Noble JG. Melatonin pharmacotherapy for nocturia in men with benign prostatic enlargement. J Urol. 2004;171:1199-1202. (Pubitemid 38327558)
8. Sugaya K, Nishijima S, Miyazato M, Kadekawa K, Ogawa Y. Effects of melatonin and rilmazafone on nocturia in the elderly. J Int Med Res. 2007;35:685-691. (Pubitemid 47570489)
9. Matsuta Y, Yusup A, Tanase K, Ishida H, Akino H, Yokoyama O. Melatonin increases bladder capacity via GABAergic system and decreases urine volume in rats. J Urol. 2010;184:386-391.
10. Semerciöz A, Onur R, Ayar A, Orhan I. The inhibitory role of melatonin on isolated guinea-pig urinary bladder: an endogenous hormone effect. BJU Int. 2004;94:1373-1376. (Pubitemid 40052111)
11. Pandi-Perumal SR, Trakht I, Srinivasan V, Spence DW, Maestroni GJ, Zisapel N, Cardinali DP. Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog Neurobiol. 2008;85:335-353.
12. Ayar A, Kutlu S, Yilmaz B, Kelestimur H. Melatonin inhibits spontaneous and oxytocin-induced contractions of rat myometrium in vitro. Neuro Endocrinol Lett. 2001;22:199-207. (Pubitemid 32677241)
13. Thor PJ, Krolczyk G, Gil K, Zurowski D, Nowak L. Melatonin and serotonin effects on gastrointestinal motility. J Physiol Pharmacol. 2007;58 Suppl 6:97-103.
14. Abrams P, Andersson KE. Muscarinic receptor antagonists for overactive bladder. BJU Int. 2007;100:987-1006. (Pubitemid 47537675)
15. Drake MJ. Emerging drugs for treatment of overactive bladder and detrusor overactivity. Expert Opin Emerg Drugs. 2008;13:431-446.
16. Nowak JZ, Zawilska JB. Melatonin and its physiological and therapeutic properties. Pharm World Sci. 1998;20:18-27. (Pubitemid 28114329)
17. Onur R, Ozcan M, Tuygun U, Ozan T, Ayar A, Orhan I. Effects of combined use of trospium chloride and melatonin on in vitro contractility of rat urinary bladder. Urology. 2010;75:873-877.
18. Pressman MR, Figueroa WG, Kendrick-Mohamed J, Greenspon LW, Peterson DD. Nocturia. A rarely recognized symptom of sleep apnea and other occult sleep disorders. Arch Intern Med. 1996;156:545-550. (Pubitemid 26077357)
19. Salvatore S, Soligo M, Proietti F, Citterio S, Artibani W, Milani R. Overactive bladder syndrome: considerations in pharmacotherapy and new perspectives. Eur J Obstet Gynecol Reprod Biol. 2005;120:129-133. (Pubitemid 40745314)
20. Cogé F, Guenin SP, Fery I, Migaud M, Devavry S, Slugocki C, Legros C, Ouvry C, Cohen W, Renault N, Nosjean O, Malpaux B, Delagrange P, Boutin JA The end of a myth: cloning and characterization of the ovine melatonin MT(2) receptor. Br J Pharmacol. 2009;158:1248-1262.
21. Ouyang H, Vogel HJ. Melatonin and serotonin interactions with calmodulin: NMR, spectroscopic and biochemical studies. Biochim Biophys Acta. 1998;1383:37-47. (Pubitemid 28130422)
22. Ozveren E, Korkmaz B, Buharalioglu CK, Tunctan B. Involvement of calcium/calmodulin-dependent protein kinase II to endotoxin-induced vascular hyporeactivity in rat superior mesenteric artery. Pharmacol Res. 2006;54:208-218. (Pubitemid 44119201)